# Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement

> **NCT07369089** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, San Diego** · enrollment: 88 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Ketamine
- **BEHAVIORAL:** Mindfulness-Oriented Recovery Enhancement (MORE)
- **BEHAVIORAL:** Support Group

## Key facts

- **NCT ID:** NCT07369089
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2028-01
- **Final completion:** 2028-04
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07369089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07369089, "Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07369089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*